Green–blue inclusions in neutrophils and monocytes: a critical finding Daniel WelderWeina Chen Images in Hematology 16 January 2022 Pages: 149 - 150
Newly diagnosed ETV6-RUNX1–positive B-acute lymphoblastic leukemia localized to the left pelvic bone marrow Minori BabaMasaru ImamuraChihaya Imai Images in Hematology 04 January 2022 Pages: 151 - 152
Isolated thrombosis after COVID-19 vaccination: case series Mona Al-AhmadMona Al RasheedNeveen Shalaby Rapid Communication 06 January 2022 Pages: 153 - 157
Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal Toshihisa NakashimaYoshihiro InamotoTetsuya Furukawa Rapid Communication 28 January 2022 Pages: 158 - 162
Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan Masahiro TakeyamaKana SasaiKeiji Nogami Original Article 01 November 2021 Pages: 163 - 172
Coagulation assay discrepancies in Japanese patients with non-severe hemophilia A Hiroshi InabaSatomi NishikawaEi Kinai Original Article 09 November 2021 Pages: 173 - 187
Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patients Akio MoriMasahiro OnozawaTakeshi Kondo Original Article 05 November 2021 Pages: 188 - 197
Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice Noriyuki SaitoTakuji YamauchiFumihiko Ishikawa Original Article 13 November 2021 Pages: 198 - 207
Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study Yoshinori HashimotoTomoki ItoNorio Komatsu Original Article 02 November 2021 Pages: 208 - 221
Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial Grzegorz S. NowakowskiWolfgang WillenbacherJavier Munoz Original Article 19 November 2021 Pages: 222 - 232
Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma Rikio SuzukiYuka KitamuraKiyoshi Ando Original Article 05 November 2021 Pages: 233 - 243
Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI Yuta YamadaShuntaro IkegawaNoriko Doki Original Article 15 October 2021 Pages: 244 - 254
Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report Abhilasha SampagarManasi GosaviNiranjana Mahantashetti Original Article 27 October 2021 Pages: 255 - 262
A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia Yuko HondaHideki MuramatsuKazuo Sakashita Original Article 29 October 2021 Pages: 263 - 268
Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children Akihisa SawadaMariko ShimizuMasami Inoue Original Article 05 November 2021 Pages: 269 - 277
NUDT15 genetic testing-guided 6-mercaptopurine dosing in children with ALL likely to be cost-saving in China XiaoXia WeiJing ZhuangJie Zhuang Original Article 28 October 2021 Pages: 278 - 286
Utility of 18F-FDG-PET for detecting acute lymphoblastic leukemia: a case series of pediatric acute lymphoblastic leukemia without hematological symptoms Yasuhiro IkawaMika TakenakaTaizo Wada Case Report 13 October 2021 Pages: 287 - 292
Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual Asuka OgaiRyuto YoshidaHideaki Nakajima Letter to the Editor 30 October 2021 Pages: 293 - 295
R-GCD regimen in elderly patients with relapsed or refractory aggressive non-Hodgkin’s B-cell lymphoma: a retrospective single-center analysis Toshiya HinoAkira HondaMineo Kurokawa Letter to the Editor 23 November 2021 Pages: 296 - 297
